This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
Sources: Australasian College of Pharmacy. Management of reflux: a guideline for pharmacists. Queensland Health. Queensland Community Pharmacy Gastro-oesophageal Reflux and Gastro-oesophageal Reflux Disease – Clinical Practice Guideline. NSW Health. NSW Pharmacist Practice Standards for gastro-oesophageal reflux and gastro-oesophageal reflux disease.[/caption]
Dr Ming S Soh PhD, BPharm (Hons)[/caption]
DR Amy Page (she/her) PhD, MClinPharm, GradDipBiostat, GCertHProfEd, GAICD, GStat, FSHPA, FPS is a consultant pharmacist, biostatistician, and the director of the Centre for Optimisation of Medicines at UWA’s School of Allied Health.[/caption]
Hui Wen Quek (she/her) BPharm(Hons), GradCertAppPharmPrac is a pharmacist and PhD candidate at the University of Western Australia (UWA).[/caption]
Gauri Godbole FPS[/caption]
How to get the most out of your PSA21 Virtual experience
There are just two days until PSA21 Virtual begins, with an exciting program of clinical, therapeutic and industry sessions for pharmacists in all practice settings.
PSA National President opening address at PSA24
Read the transcript of the speech delivered by PSA National President Associate Professor Fei Sim FPS at PSA24 today (2 August).
Visionary pharmacist named year’s best at PSA18
John Jackson FPS has been named PSA Pharmacist of the Year for his decades-long commitment to developing new practice and funding models, and for...
Bushfire crisis brings out the best in pharmacists
It has been a tough start to 2020 for many Australians. The bushfire crisis has engulfed Australia, affecting virtually all states and territories.
Record number of COVID-19 vaccines administered
Hundreds of Victorians are on alert after potential exposure to the virus, as more Australians line up to receive the vaccine.
Tips for extended telehealth consultations for medicines reviews
In response to the COVID-19 pandemic, pharmacists may continue delivering medicine reviews via telehealth until 31 March 2021.
